HIF1A and ovarian carcinoma: Ai et al. [202] reported that overexpression of degradation-resistant HIF-1α suppresses cisplatin-induced apoptosis while genetic knockdown of HIF-1α or pharmacological promotion of HIF-1α degradation enhances the response to cisplatin in ovarian cancer cells.